Autolus Therapeutics Plc
(NASDAQ) AUTL
Autolus Therapeutics Plc Financials at a Glance
Market Cap
$375.26M
Revenue (TTM)
$75.35M
Net Income (TTM)
$287.40M
EPS (TTM)
$-1.08
P/E Ratio
-1.31
Dividend
$0.00
Beta (Volatility)
1.09 (Average)
Dividend
$0.00
Beta (Volatility)
1.09 (Average)
Price
$1.41
Volume
1,033,400.475
Open
$1.33
Price
$1.41
Volume
1,033,400.475
Open
$1.33
Previous Close
$1.41
Daily Range
$1.31 - $1.42
52-Week Range
$1.10 - $2.70
Dividend
$0.00
Beta (Volatility)
1.09 (Average)
Price
$1.41
Volume
1,033,400.475
Open
$1.33
Previous Close
$1.41
Daily Range
$1.31 - $1.42
52-Week Range
$1.10 - $2.70
AUTL News
AUTL: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Autolus Therapeutics Plc
Industry
Biotechnology
Sector
Health CareEmployees
752
CEO
Christian Martin Itin, PhD
Website
www.autolus.comHeadquarters
London, W12 7FP, GB
AUTL Financials
Key Financial Metrics (TTM)
Gross Margin
-28%
Operating Margin
-4%
Net Income Margin
-4%
Return on Equity
-95%
Return on Capital
-52%
Return on Assets
-49%
Earnings Yield
-76.34%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$375.26M
Shares Outstanding
266.14M
Volume
1.03M
Short Interest
0.00%
Avg. Volume
1.89M
Financials (TTM)
Gross Profit
$21.03M
Operating Income
$281.44M
EBITDA
$271.60M
Operating Cash Flow
$283.57M
Capital Expenditure
$19.09M
Free Cash Flow
$303.32M
Cash & ST Invst.
$300.71M
Total Debt
$351.59M
Autolus Therapeutics Plc Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$24.25M
+83534.2%
Gross Profit
$1.04M
+99.2%
Gross Margin
-4.29%
N/A
Market Cap
$375.26M
N/A
Market Cap/Employee
$580.00K
N/A
Employees
647
N/A
Net Income
$90.20M
-226.7%
EBITDA
$72.36M
+1.9%
Quarterly Fundamentals
Net Cash
$50.88M
-109.5%
Accounts Receivable
$75.26M
+56.0%
Inventory
$33.21M
+702.5%
Long Term Debt
$337.02M
+579.1%
Short Term Debt
$14.56M
+385.8%
Return on Assets
-48.79%
N/A
Return on Invested Capital
-52.45%
N/A
Free Cash Flow
$91.09M
-47.4%
Operating Cash Flow
$67.32M
-77.5%